These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 24970218)
1. Re-configuration of sphingolipid metabolism by oncogenic transformation. Don AS; Lim XY; Couttas TA Biomolecules; 2014 Mar; 4(1):315-53. PubMed ID: 24970218 [TBL] [Abstract][Full Text] [Related]
2. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids. Kihara A Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042 [TBL] [Abstract][Full Text] [Related]
4. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210 [TBL] [Abstract][Full Text] [Related]
5. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564 [TBL] [Abstract][Full Text] [Related]
6. Sphingolipid metabolism in cancer signalling and therapy. Ogretmen B Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025 [TBL] [Abstract][Full Text] [Related]
7. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity. Tabuchi K; Hara A Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830 [TBL] [Abstract][Full Text] [Related]
8. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures. Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280 [TBL] [Abstract][Full Text] [Related]
9. Targeting the Sphingolipid Rheostat in Gliomas. Zaibaq F; Dowdy T; Larion M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521 [TBL] [Abstract][Full Text] [Related]
11. Cancer treatment strategies targeting sphingolipid metabolism. Oskouian B; Saba JD Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655 [TBL] [Abstract][Full Text] [Related]
12. Role of bioactive sphingolipids in physiology and pathology. Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188 [TBL] [Abstract][Full Text] [Related]
13. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Kihara A; Mitsutake S; Mizutani Y; Igarashi Y Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104 [TBL] [Abstract][Full Text] [Related]
15. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256 [TBL] [Abstract][Full Text] [Related]
17. S1P metabolism in cancer and other pathological conditions. Leong WI; Saba JD Biochimie; 2010 Jun; 92(6):716-23. PubMed ID: 20167244 [TBL] [Abstract][Full Text] [Related]
18. [Sphingosine kinase 1 and tumor]. Zhang CX; He HW; Shao RG Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR. Aoyama Y; Sobue S; Mizutani N; Inoue C; Kawamoto Y; Nishizawa Y; Ichihara M; Kyogashima M; Suzuki M; Nozawa Y; Murate T Biochem Biophys Res Commun; 2017 Apr; 486(2):551-557. PubMed ID: 28322796 [TBL] [Abstract][Full Text] [Related]
20. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities. Blaho VA Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]